Weight Loss and Obesity Management Market
The global weight loss and obesity management market is expected to exhibit a CAGR of 7.2% during the forecast period (2019-2027), owing to product launches, and increasing investment in research and development by manufacturers. For instance, in September 2019, the U.S. FDA approved Novo Nordisk semaglutide which is a new diabetes drug that reduces blood sugar levels and also helps people lose weight significantly. Its once-a-week shot for people with type 2 diabetes.
Related Bookmarks
- Make Growth and Development Appointments Fun - Yang Orthodontics
- Oral Hygiene for People with Braces - Yang Orthodontics
- What is the pilates knee pain relief principle for knee injuries?
- Docs must renew licence every 5 years: KMC
- Effective Tips to Select the Right Hair Transplant Surgeon
- Anesthesia and Respiratory Devices Market Growth
- Global Infertility Devices Market Analysis
- When You Should Concern a Knee Pain Doctor?
- Physical Therapy in Miami - 24/7 Home Health Care
- U.S. Ambulatory Surgery Centers Market
Recent Profiles
123b
Hồng Hạc City
Sunwin
Mastertint Oxenford
Niral Farms
Devin Burns
8xbet
Ball88
Ewoke Innovative Solutions Pvt Ltd
Nhà Cái Dn88